Recent brand partnerships at Ulta Beauty (ULTA) are back in focus after the retailer agreed to exclusively launch Nutrire in August 2026 and to add Chinese skincare company PROYA to its prestige assortment later this year.

Against this backdrop of new brand launches and board changes, Ulta Beauty’s share price has recently firmed, with a 7.85% 1 month share price return and a 1.25% 3 month share price return, while the year to date share price return has declined 15.90% and the 1 year total shareholder return is slightly lower at 1.52%.

If this kind of brand driven growth story interests you, it can be useful to see which other retailers and consumer companies are also broadening their product ranges through founder leadership and tight execution. Now might be a good time to check out the 21 top founder-led companies

Bulls see Ulta Beauty’s recent brand additions and board refresh as a platform for future gains. Bears focus on the share price pullback and mixed recent returns. Which side do the current valuation numbers lean toward?

Most Popular Narrative: 16.9% Undervalued

The most followed narrative for Ulta Beauty compares a fair value of $627.25 with the last close at $521.46, framing the stock as trading at a discount based on long term earnings power and brand expansion.

Record loyalty membership (now 45.8 million) and continued strong program engagement, together with omnichannel strategies and brand differentiation, lay the foundation for sustainable increases in repeat purchase rates and customer lifetime value, positively impacting revenue consistency and resilient earnings.

Want to see how this loyalty engine feeds into the valuation gap? The narrative leans heavily on steady earnings growth, modest margin expansion, and a richer future earnings multiple. Curious which specific revenue and profit paths need to play out to support that $627.25 figure?

Result: Fair Value of $627.25 (UNDERVALUED)

However, Ulta Beauty still faces pressure from rising store and labor costs, and the planned end of the Target partnership could weigh on future earnings quality.

Another View On Ulta Beauty’s Valuation

The first narrative leans on analyst forecasts and a higher future P/E to argue Ulta Beauty is 16.9% undervalued. A different lens uses the current P/E of 18.9x versus a fair ratio of 17.4x, which suggests the stock screens as a little expensive. Which signal do you weigh more heavily?

On current numbers, Ulta Beauty trades on a P/E below the peer average of 26.5x and roughly in line with the US Specialty Retail industry at 19x, yet still above the 17.4x fair ratio that our model suggests the market could move toward. That gap points to some valuation risk if expectations or sentiment cool.

Next Steps

With sentiment split on Ulta Beauty’s valuation and growth path, it makes sense to check the underlying data soon and decide where you stand. To see what investors are currently optimistic about in the numbers, take a closer look at the 2 key rewards

Looking for more investment ideas beyond Ulta Beauty?

If Ulta Beauty has sharpened your interest, now is the moment to widen your watchlist with other clear opportunities picked out by the Simply Wall St Screener.

• Target reliable income by reviewing companies filtered as potential 12 dividend fortresses that may suit investors seeking stronger cash returns.
• Hunt for value by checking stocks our tools flag as screener containing 19 high quality undiscovered gems before they appear on more radars.
• Prioritise resilience by focusing on businesses highlighted in the 78 resilient stocks with low risk scores that may better handle tougher conditions.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.